Scientific Advisory Board
The idea for FLIP was born out of real science and a passion for human health, safety and sexual wellness. Our scientific advisory board ensures that our product development is grounded in real research and adheres to safety standards.
Dr Bob Buckheit
Dr. Robert (Bob) Buckheit is President and Chief Scientific Officer of ImQuest BioSciences and Executive Vice President of ImQuest Pharmaceuticals, companies that he founded in 2004 and 2005. During his 30 years of experience in antiviral and microbiology research Bob has assisted academic researchers, biotechnology companies, and pharmaceutical companies to develop agents to treat infectious disease based on his expertise in drug screening, and mechanism of action, resistance and combination drug evaluations. Bob’s research has resulted in over 175 publications in the peer review literature, especially involving the development of HIV therapeutic and prevention products.
Specialties: Virology (HIV, HCV, HBV, influenza); Drug Discovery and Development.
Dr David Katz
Dr. David Katz received his Ph.D. in Engineering Science from the University of California, Berkeley in 1972. He is currently a Professor of Biomedical Engineering and of Obstetrics & Gynecology at Duke University. His research interests focus upon women’s health, and include methods for prophylaxis against sexually transmitted diseases, contraception, diagnosis and treatment of cervical cancer, and prevention and treatment of post-partum hemorrhage. Dr. Katz has vast knowledge and experience in the field of reproductive biology and medicine with a focus on the deployment and delivery of well formulated products to the genital tract. His expertise in the biomechanics of gel spreading in the rectal and vaginal compartments was used to optimize several iterations of gels and lubricants in the evolution of FLIP.
Mr. Ed Fuchs
Mr. Fuchs is the Associate Director of the Drug Development Unit in the Division of Clinical Pharmacology at Johns Hopkins University. He holds a research associate appointment in the Department of Medicine in the Johns Hopkins School of Medicine and in the Department of Epidemiology in the Johns Hopkins Bloomberg School of Public Health.
His primary research interest is in pilot studies of prevention of HIV transmission, where he published one of the first clinical studies looking at the effects of personal lubricants on the lining of the colon, as well as a number of studies on imaging the distribution of personal lubricants in the vagina and colon. He has participated in advisory note review and expert panel meetings where he has presented on the effects of personal lubricants on the mucosal lining.
Based on our initial data, FLIP is likely to be one of the best and safest lubes on the market: pretty good combination!